大脑静脉鼻血栓和预后因素的探索:一个案例系列
Jiahui Liu1, Junfeng Yang1, Yu Fan1
1Department of Neurology, Baotou Central Hospital, Baotou, China.
Frontiers in neurology
|December 2, 2024
概括
大脑静脉鼻血栓症 (CVST) 影响年轻的成年人,怀孕是常见的危险因素. 在随访时,国家卫生研究院中风量表 (NIHSS) 较高的得分预测3个月后的结果不佳.
科学领域:
- 神经学 神经学
- 血管医学 血管医学
- 血栓形成研究研究
背景情况:
- 大脑静脉鼻血栓 (CVST) 是一种罕见但严重的疾病.
- 了解其风险因素,临床表现和结果对于患者管理至关重要.
研究的目的:
- 调查诊断为CVST的患者的病因,治疗反应和预后.
- 确定CVST患者不良结果的预测因素.
主要方法:
- 对31名在2016年至2020年期间被诊断为CVST患者的回顾性研究.
- 收集的数据包括人口统计,并发症,临床表现,放射学发现和治疗.
- 分析了患者的特征和结果,包括格拉斯哥昏迷度量 (GCS),NIHSS和修改的兰金度量 (mRS).
主要成果:
- CVST患者的平均年龄为39岁,其中大多数是女性 (58%).
- 怀孕 (19.4%) 和血栓性疾病 (12.9%) 是显著的危险因素.
- 在表现好与表现差的患者之间,没有发现基线特征的显著差异 (mRS 0与>0).
结论:
- 在随访时,国家卫生研究院中风量表 (NIHSS) 的得分大于0是3个月修改的兰金量表 (mRS) 得分差 (>0) 的唯一有意义的预测因素.
- 早期识别和管理导致NIHSS得分升高的因素可能会改善CVST患者的长期预后.
相关概念视频
Aneurysm II: Clinical Manifestations and Diagnostic Studies
589
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
589
Varicose Veins II: Diagnostic Studies and Interprofessional Care
319
Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...
319
Venous Thrombosis I: Introduction
822
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
822
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
469
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
469
Venous Thrombosis III: Interprofessional Care
482
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
482
Cerebral Edema ll: Pathophysiology
19
Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this...
19


